{"id":"https://openalex.org/W4245294341","doi":"https://doi.org/10.1016/s0960-894x(97)10081-6","title":"Bisbenzamidine isoxazoline derivatives as factor Xa inhibitors","display_name":"Bisbenzamidine isoxazoline derivatives as factor Xa inhibitors","publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W4245294341","doi":"https://doi.org/10.1016/s0960-894x(97)10081-6"},"language":"en","primary_location":{"id":"doi:10.1016/s0960-894x(97)10081-6","doi":"https://doi.org/10.1016/s0960-894x(97)10081-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(97)10081-6","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030883249","display_name":"Mimi L. C. Quan","orcid":"https://orcid.org/0000-0001-5866-0114","observed_orcids":["https://orcid.org/0000-0001-5866-0114"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.L. Quan","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082976193","display_name":"James R. Pruitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.R. Pruitt","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016508176","display_name":"Christopher D. Ellis","orcid":"https://orcid.org/0000-0002-4581-2841","observed_orcids":["https://orcid.org/0000-0002-4581-2841"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.D. Ellis","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003290621","display_name":"Ann Y. Liauw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.Y. Liauw","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044117839","display_name":"Robert A. Galemmo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.A. Galemmo","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080879196","display_name":"Pieter F. W. Stouten","orcid":"https://orcid.org/0000-0002-5203-2202","observed_orcids":["https://orcid.org/0000-0002-5203-2202"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P.F.W. Stouten","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083770969","display_name":"John Wityak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Wityak","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084860922","display_name":"Robert M. Knabb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.M. Knabb","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108800429","display_name":"Martin Thoolen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.J. Thoolen","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026904604","display_name":"Pancras C. Wong","orcid":"https://orcid.org/0000-0002-8224-7423","observed_orcids":["https://orcid.org/0000-0002-8224-7423"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P.C. Wong","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003421053","display_name":"Ruth R. Wexler","orcid":"https://orcid.org/0000-0001-5514-5053","observed_orcids":["https://orcid.org/0000-0001-5514-5053"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.R. Wexler","raw_affiliation_strings":["The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Merck Pharmaceutical Company, P.O. Box 80500 Wilmington, DE 19880-0500 USA","institution_ids":["https://openalex.org/I1316910977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1316910977"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.8926,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.91060904,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"7","issue":"21","first_page":"2813","last_page":"2818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.017899999395012856,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":0.9110000133514404},{"id":"https://openalex.org/keywords/isoxazoline-derivatives","display_name":"isoxazoline derivatives","score":0.9570000171661377},{"id":"https://openalex.org/keywords/serine-protease-inhibition","display_name":"serine protease inhibition","score":0.9229999780654907},{"id":"https://openalex.org/keywords/blood-coagulation","display_name":"coagulation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.746999979019165},{"id":"https://openalex.org/keywords/anticoagulant-drug-design","display_name":"anticoagulant drug design","score":0.7839999794960022},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8861494660377502},{"id":"https://openalex.org/C2777807008","wikidata":"https://www.wikidata.org/wiki/Q87324999","display_name":"Serine protease","level":4,"score":0.7212401628494263},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.69899582862854},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.6515254974365234},{"id":"https://openalex.org/C3019190606","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation cascade","level":4,"score":0.5827341079711914},{"id":"https://openalex.org/C57002609","wikidata":"https://www.wikidata.org/wiki/Q5281999","display_name":"Discovery and development of direct thrombin inhibitors","level":4,"score":0.5420154333114624},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5119513273239136},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4550555348396301},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.4388892352581024},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.40426695346832275},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.3976955711841583},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3321036994457245},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.12782889604568481},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10045778751373291},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0853772759437561},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0960-894x(97)10081-6","doi":"https://doi.org/10.1016/s0960-894x(97)10081-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(97)10081-6","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1593430977","https://openalex.org/W1973071909","https://openalex.org/W2011663339","https://openalex.org/W2038122625","https://openalex.org/W2061613237","https://openalex.org/W2070055345","https://openalex.org/W2076978563","https://openalex.org/W2414560271"],"related_works":["https://openalex.org/W2175358956","https://openalex.org/W2180360918","https://openalex.org/W2049527791","https://openalex.org/W2106451839","https://openalex.org/W2006194634","https://openalex.org/W1984625302","https://openalex.org/W2949086983","https://openalex.org/W4240397901","https://openalex.org/W4230997406","https://openalex.org/W2089159489"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}